News | March 13, 2013

First Commercial Installation of GE’s Optima NM/CT 640 System Announced

Texas Health Harris Methodist Hospital Fort Worth adds imaging capabilities with high-precision, low radiation dose SPECT/CT technology

March 13, 2013 — GE Healthcare announced last month the first global commercial installation of its Optima NM/CT 640 technology, a new performance SPECT/CT (single-photon emission computed tomography/computed tomography) system that helps physicians balance high image quality with low patient radiation dose and efficiency. The installation is at Texas Health Harris Methodist Hospital Fort Worth in Fort Worth, Texas.

The Optima NM/CT 640 enables clinicians to focus on key needs in diagnostic imaging, including high-quality visuals, low radiation dose and short exam times for patients. The Optima NM/CT 640 allows for hybrid imaging rather than standalone CT use, integrating the latest generation general purpose camera with a newly developed four-slice CT. Available in 2.5 mm and 5 mm slice thicknesses, the CT technology is designed to optimize dose and resolution required for particular procedures, offering clinicians high-quality images with routinely low CT dose at 1-2 mSv for a 40 cm abdomen CT scan.

The Optima NM/CT 640 requires minimal renovation and installation costs and can be fully upgraded for future use, expanding its clinical applications as well as offering the potential for research capabilities. When used with the Xeleris workstation, Optima NM/CT allows clinicians to potentially reduce time or injected patient dose by up to 50 percent in most scanning procedures while maintaining image quality.

“We are dedicated to pushing nuclear medicine to its full potential and developing equipment that helps customers address the challenges they are confronted with every day — high image quality, low dose and short exam times,” said Nathan Hermony, general manager, nuclear medicine, GE Healthcare. “We are pleased to collaborate with clinical leaders at Texas Health Harris Methodist Hospital Fort Worth on the first global installation of Optima NM/CT 640 technology as they continue to deliver diagnostic excellence and quality patient care.”

Texas Health Fort Worth is a 726-bed, Magnet-designated regional referral center with more than 4,000 employees, 200 volunteers and nearly 1,000 physicians practicing on the medical staff. The hospital’s services include cardiovascular services, high-risk and routine obstetrics and gynecology, orthopedics and sports medicine, neonatal intensive care, and trauma/emergency medicine. Texas Health Fort Worth is an affiliate of the faith-based, nonprofit Texas Health Resources system.

For more information: www.gehealthcare.com

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a
Sponsored Content | Videos | Clinical Decision Support | June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Dual-Agent PET/MR With Time of Flight Detects More Cancer

Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.

News | PET-MRI | June 20, 2017
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (...
Combined Optical and Molecular Imaging Could Guide Breast-Conserving Surgery

WLE specimen from a patient with a grade 3, ER-/HER2-, no special type (NST) carcinoma. (A) Cerenkov image; (B) Grey-scale photographic image overlaid with Cerenkov signal. An increased signal from the tumor is visible (white arrows); mean radiance is 871 ± 131 photons/s/cm2/sr, mean TBR is 3.22. Both surgeons measured the posterior margin (outlined in blue) as 2 mm (small arrow); a cavity shaving would have been performed if the image had been available intraoperatively. The medial margin (outlined in green) measured >5 mm by both surgeons. Pathology ink prevented assessing the lateral margin; a phosphorescent signal is visible (open arrows). (C) Specimen radiography image. The absence of one surgical clip to mark the anterior margin, and the odd position of the superior margin clip (white arrow) prevented reliable margin assessment. (D) Combined histopathology image from two adjacent pathology slides on which the posterior margin (bottom of image) and part of the primary tumor are visible (open arrows). The distance from the posterior margin measured 3 mm microscopically (double arrow). The medial margin is > 5 mm (not present in image). Credit: A. D. Purushotham, M.D., King’s College London, UK

News | Nuclear Imaging | June 20, 2017
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage...
A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging

A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging. Graphic courtesy of the Department of Nuclear Medicine, Royal North Shore Hospital, Sydney

News | Prostate Cancer | June 15, 2017
An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific...
Overlay Init